Further research is needed to evaluate the effect of liraglutide on decreasing or discontinuing insulin therapy, the effect of insulin rescue on BMI reduction in children and adolescents with T2D, and the effect of higher doses of liraglutide on BMI in children and adolescents with obesity and diabetes. Here, INS is linked to obesity disorder.